Pillbox organizers are associated with improved adherence to HIV antiretroviral therapy and viral suppression: a marginal structural model analysis.

BACKGROUND Pillbox organizers are inexpensive and easily used; however, their effect on adherence to antiretroviral medications is unknown. METHODS Data were obtained from an observational cohort of 245 human immunodeficiency virus (HIV)-infected subjects who were observed from 1996 through 2000 in San Francisco, California. Adherence was the primary outcome and was measured using unannounced monthly pill counts. Plasma HIV RNA level was considered as a secondary outcome. Marginal structural models were used to estimate the effect of pillbox organizer use on adherence and viral suppression, adjusting for confounding by CD4+ T cell count, viral load, prior adherence, recreational drug use, demographic characteristics, and current and past treatment. RESULTS Pillbox organizer use was estimated to improve adherence by 4.1%-4.5% and was associated with a decrease in viral load of 0.34-0.37 log10 copies/mL and a 14.2%-15.7% higher probability of achieving a viral load < or = 400 copies/mL (odds ratio, 1.8-1.9). All effect estimates were statistically significant. CONCLUSION Pillbox organizers appear to significantly improve adherence to antiretroviral therapy and to improve virologic suppression. We estimate that pillbox organizers may be associated with a cost of approximately $19,000 per quality-adjusted life-year. Pillbox organizers should be a standard intervention to improve adherence to antiretroviral therapy.

[1]  Mark J van der Laan,et al.  Deletion/Substitution/Addition Algorithm in Learning with Applications in Genomics , 2004, Statistical applications in genetics and molecular biology.

[2]  J. Robins,et al.  Marginal Structural Models and Causal Inference in Epidemiology , 2000, Epidemiology.

[3]  B. Yip,et al.  Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up , 2002, AIDS.

[4]  J. Cramer,et al.  Cue-dose training with monetary reinforcement: pilot study of an antiretroviral adherence intervention. , 2000, Journal of general internal medicine.

[5]  A. Rodgers,et al.  Do fixed-dose combination pills or unit-of-use packaging improve adherence? A systematic review. , 2004, Bulletin of the World Health Organization.

[6]  Why Prefer Double Robust Estimates? Illustration with Causal Point Treatment Studies , 2002 .

[7]  Justin C McArthur,et al.  A programmable prompting device improves adherence to highly active antiretroviral therapy in HIV-infected subjects with memory impairment. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  A. Zolopa,et al.  HIV and tuberculosis infection in San Francisco's homeless adults. Prevalence and risk factors in a representative sample. , 1994, JAMA.

[9]  A. Carballo-Diéguez,et al.  Couple-focused support to improve HIV medication adherence: a randomized controlled trial , 2005, AIDS.

[10]  Susan Swindells,et al.  Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV Infection , 2000, Annals of Internal Medicine.

[11]  D. Berry,et al.  Statistical models in epidemiology, the environment, and clinical trials , 2000 .

[12]  Jeannie K. Lee,et al.  Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. , 2006, JAMA.

[13]  F. Hecht,et al.  Comparing Objective Measures of Adherence to HIV Antiretroviral Therapy: Electronic Medication Monitors and Unannounced Pill Counts , 2001, AIDS and Behavior.

[14]  H. Günthard,et al.  Effect of Individual Cognitive Behaviour Intervention on Adherence to Antiretroviral Therapy: Prospective Randomized Trial , 2004, Antiviral therapy.

[15]  L. Appel,et al.  Impact of pill organizers and blister packs on adherence to pill taking in two vitamin supplementation trials. , 2000, American journal of epidemiology.

[16]  A. Zolopa,et al.  Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. , 2001, AIDS.

[17]  F. Hecht,et al.  Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population , 2000, AIDS.

[18]  Mark J. van der Laan,et al.  Why prefer double robust estimators in causal inference , 2005 .

[19]  J. Robins,et al.  Estimating the causal effect of zidovudine on CD4 count with a marginal structural model for repeated measures , 2002, Statistics in medicine.

[20]  Milton C Weinstein,et al.  Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infection. , 2003, The American journal of medicine.

[21]  J. Caylà,et al.  Impact of Adherence and Highly Active Antiretroviral Therapy on Survival in HIV‐Infected Patients , 2002, Journal of acquired immune deficiency syndromes.

[22]  A. Lippman.  Adherence to medication. , 2005, The New England journal of medicine.

[23]  James M. Robins,et al.  Unified Methods for Censored Longitudinal Data and Causality , 2003 .

[24]  Marilyn M. Wagener,et al.  Adherence to protease inhibitor therapy and outcomes in patients with HIV infection (vol 133, pg 21, 2000) , 2002 .

[25]  G. Wagner,et al.  Electronic monitoring: Adherence assessment or intervention? , 2002, HIV clinical trials.

[26]  James M. Robins,et al.  Marginal Structural Models versus Structural nested Models as Tools for Causal inference , 2000 .

[27]  D. Bangsberg,et al.  HIV seroprevalence among homeless and marginally housed adults in San Francisco. , 2004, American journal of public health.

[28]  K. Farmer,et al.  Impact of an adherence clinic on behavioral outcomes and virologic response in treatment of HIV infection: a prospective, randomized, controlled pilot study. , 2005, Clinical therapeutics.

[29]  J E Winland-Brown,et al.  Effectiveness of different medication management approaches on elders' medication adherence. , 2000, Outcomes management for nursing practice.

[30]  Loren G. Miller,et al.  A prospective study of predictors of adherence to combination antiretroviral medication , 2002, Journal of General Internal Medicine.

[31]  R. Grant,et al.  Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.